SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001808805-22-000003
Filing Date
2022-02-24
Accepted
2022-02-23 17:44:28
Documents
14
Period of Report
2022-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K naut-20220224.htm   iXBRL 8-K 36611
2 EX-99.1 exhibit991-2021q48xk.htm EX-99.1 104356
  Complete submission text file 0001808805-22-000003.txt   319264

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT naut-20220224.xsd EX-101.SCH 2156
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT naut-20220224_def.xml EX-101.DEF 6278
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT naut-20220224_lab.xml EX-101.LAB 29739
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT naut-20220224_pre.xml EX-101.PRE 17919
8 EXTRACTED XBRL INSTANCE DOCUMENT naut-20220224_htm.xml XML 12848
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Filer) CIK: 0001808805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39434 | Film No.: 22665253
SIC: 3826 Laboratory Analytical Instruments